GET DAILY SIGNALSJanus Living (JAN) Delivers Strong Q3 Revenue Growth of 78% Year Over Year
Key Takeaways
- Janus Living reported third quarter 2026 total revenue of $268.3 million, up 78% year over year and roughly $20.9 million above consensus expectations.
- GAAP diluted earnings per share came in at -$0.02, missing estimates as acquisition-related depreciation weighed on net income.
- FFO as adjusted per diluted share rose 46% year over year to $0.25, a key profitability measure for real estate investors.
- Same-store adjusted NOI climbed 25.9%, signaling strong performance at existing properties, not just newly acquired ones.
- Management raised full-year 2026 FFO as adjusted guidance to $0.97–$0.99 and lifted its same-store NOI growth outlook.
- For more context on this company, explore Major News, Today's Price Move, Price Targets, and Forecast on dedicated analysis pages.
- Discover actionable trade ideas powered by AI through Trending AI Robots.
Why This Quarter Matters
Janus Living operates as a pure-play senior housing REIT that went public in early 2026. This marks one of its first full reporting periods as an independent company. The third quarter stands out because it shows the impact of an aggressive acquisition strategy, with roughly $1.75 billion deployed in the period. With Healthpeak Properties holding about 69% of the business, attention centers on whether the new communities can drive higher funds from operations and maintain same-store growth beyond simply expanding the asset base.
Breaking Down the Reported Results
For the quarter ended September 30, 2026, total revenue reached $268.3 million, up 78% from $150.5 million in the prior-year period and about $20.9 million above consensus. GAAP diluted earnings per share landed at -$0.02, missing estimates. Management pointed to depreciation and amortization from the senior housing acquisitions closed during the quarter as the main factor.
REIT-focused metrics told a stronger story. FFO as adjusted per diluted share hit $0.25, up 46% from $0.17 a year earlier, while Nareit FFO per diluted share was $0.24. Same-store adjusted NOI rose 25.9% year over year, and adjusted EBITDAre increased 101% to roughly $105 million. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Guidance was updated as well. Full-year 2026 diluted FFO as adjusted was raised to a range of $0.97 to $0.99, and same-store adjusted NOI growth guidance increased by 250 basis points to 16%–19%. GAAP diluted earnings per share guidance was lowered to $0.08–$0.10 due to the added depreciation and amortization.
Market Reaction and Investor Focus
Shares of JAN traded modestly lower in after-hours activity following the release. The reaction reflects a mixed picture: revenue and FFO as adjusted beat expectations, yet the GAAP loss highlights how acquisition-related depreciation can mask underlying cash generation. Investors are focused on integration of the acquisition pipeline and whether same-store growth can stay robust. The raised FFO guidance and solid same-store NOI growth came across as positive, while the lowered GAAP EPS outlook reflects the accounting effects of rapid expansion.
Looking Ahead: Factors to Watch
Investors will want to track progress on the acquisition pipeline. The company completed about $1.75 billion in acquisitions during the third quarter and another $370 million through October 30, with binding agreements for roughly $82 million more still pending. Management noted target returns on recently acquired communities in the low-6% initial cash NOI yield range, improving to 7.5%–8.5% upon stabilization.
Integration costs, occupancy trends, and labor expenses remain key areas to monitor. With same-store adjusted NOI growth now guided to 16%–19%, the market will assess whether existing properties can sustain that pace as new assets stabilize. The gap between GAAP earnings and FFO will stay important too. As depreciation and amortization rise with a larger portfolio, headline EPS may face pressure even as funds from operations grow. Tracking FFO as adjusted, same-store NOI, and acquisition execution should provide the clearest view of operating health.
Using Tickeron AI Tools in My Research
I often turn to Tickeron’s AI Screener when evaluating names like this one. It lets me quickly filter stocks by fundamentals, technical patterns, and industry trends, which helps confirm whether a company’s results align with broader sector movements. The tool has become a regular part of how I cross-check ideas before digging deeper into earnings or guidance updates.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
JAN's Indicator enters downward trend
The Aroon Indicator for JAN entered a downward trend on November 02, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 168 similar instances where the Aroon Indicator formed such a pattern. In 146 of the 168 cases the stock moved lower. This puts the odds of a downward move at 87%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on JAN as a result. In 45 of 53 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 85%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where JAN's RSI Indicator exited the oversold zone, 23 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 34 of 41 cases where JAN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for JAN just turned positive on October 30, 2026. Looking at past instances where JAN's MACD turned positive, the stock continued to rise in 26 of 28 cases over the following month. The odds of a continued upward trend are 90%.
Following a +1.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where JAN advanced for three days, in 134 of 161 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
JAN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 39 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 45 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.441) is normal, around the industry mean (2.200). JAN's P/E Ratio (-113.521) is considerably lower than the industry average of (18.375). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (6.621). Dividend Yield (0.007) settles around the average of (0.237) among similar stocks. P/S Ratio (7.413) is also within normal values, averaging (5.580).
The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. JAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a company, which engages in the provision of turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs
Industry MediaConglomerates
Advertisement